Invo Fertility Inc (IVF) Stock Price, Quote & News

Company Profile

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-30...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 878 9505

Website: www.invobioscience.com

Address:

5582 Broadcast Court, Sarasota, United States

Craigknowsbest Mar. 20 at 9:03 PM

$IVF Bottom`s in. Volume was 81k until just before the close,which showed there aren`t any more sellers to take shares from. Then the volume for the day doubled as insiders bought in,knowing the bottom was in. Up Monday--

0 · Reply

LosersMakeMillions Mar. 19 at 3:18 PM

$IVF no more babies 👶🏽 🤷🏽‍♀️…

1 · Reply

Craigknowsbest Mar. 19 at 2:55 PM

$IVF This stock is way oversold technically,n it`s due to bounce to 2.00. It`s all about the earnings call,n the street is pricing in catastrophe. Estimates are for a -.55 loss per share,but the current share price has a much bigger loss per share priced in. IMO,it`s a screaming buy,n a bounce off the earnings call should be decent.

2 · Reply

Weerasuk1994 Mar. 19 at 2:10 PM

$IVF very good 💩💩💩💩

0 · Reply

Traydsman Mar. 19 at 2:33 AM

$IVF

0 · Reply

Gamecock1 Mar. 18 at 2:59 PM

$IVF thank you IVF management. I trusted you with $20,000 of my money because you promised a revolutionary way to make families. Unfortunately, I’ve lost that $20,000 and I can think of 1000s of way to piss away that money and enjoy it

3 · Reply

Topdog007 Mar. 18 at 2:28 PM

$IVF should be at 0 in 1 month. Goes down 2 cents per day, only 36 days left and we are at 0 👍👍 keep up the good work management

0 · Reply

Topdog007 Mar. 18 at 1:43 PM

$IVF CEO

0 · Reply

Topdog007 Mar. 18 at 1:42 PM

$IVF CFO

0 · Reply

Topdog007 Mar. 18 at 1:42 PM

$IVF PURE HORSESHIT

1 · Reply

INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic

Mar 3, 2026, 8:45 AM EST - 18 days ago

INVO Fertility's Wisconsin Clinic Joins Progyny Network

Feb 19, 2026, 8:30 AM EST - 4 weeks ago

INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”

Feb 11, 2026, 8:30 AM EST - 5 weeks ago

INVO Fertility Announces Patent Issuance for Modified INVOcell® Device

Feb 4, 2026, 9:00 AM EST - 6 weeks ago

INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth

Jan 13, 2026, 4:15 PM EST - 2 months ago

INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

Dec 17, 2025, 9:00 AM EST - 3 months ago

INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”

Dec 2, 2025, 9:25 AM EST - 3 months ago

INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Nov 28, 2025, 1:05 PM EST - 4 months ago

INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”

Nov 25, 2025, 9:00 AM EST - 4 months ago

INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025

Nov 17, 2025, 8:30 AM EST - 4 months ago

INVO Fertility Announces Third Quarter 2025 Financial Results

Oct 27, 2025, 8:30 AM EDT - 5 months ago

INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO's Wisconsin Fertility Institute

Sep 29, 2025, 5:30 PM EDT - 6 months ago

INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Aug 14, 2025, 5:34 PM EDT - 7 months ago

INVO Fertility Announces Second Quarter 2025 Financial Results

Jul 17, 2025, 8:00 AM EDT - 8 months ago

INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025

Jul 9, 2025, 9:00 AM EDT - 9 months ago

INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing

Jun 30, 2025, 9:00 AM EDT - 9 months ago

INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute

Jun 25, 2025, 9:00 AM EDT - 9 months ago

INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent

Jun 20, 2025, 9:00 AM EDT - 9 months ago

INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time

Jun 18, 2025, 9:00 AM EDT - 9 months ago

INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute

Jun 16, 2025, 9:00 AM EDT - 9 months ago

INVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025

May 27, 2025, 5:00 PM EDT - 10 months ago

INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

May 20, 2025, 4:05 PM EDT - 10 months ago

INVO Fertility Announces First Quarter 2025 Financial Results

Apr 30, 2025, 9:00 AM EDT - 11 months ago

INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA

Apr 24, 2025, 9:00 AM EDT - 11 months ago

INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”

Apr 14, 2025, 7:30 PM EDT - 1 year ago

NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”

Mar 13, 2025, 4:30 PM EDT - 1 year ago

NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025

Feb 25, 2025, 8:00 AM EST - 1 year ago

NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment

Feb 19, 2025, 9:15 AM EST - 1 year ago

NAYA Biosciences Announces Nomination of New Board Members

Craigknowsbest Mar. 20 at 9:03 PM

0 · Reply

LosersMakeMillions Mar. 19 at 3:18 PM

$IVF no more babies 👶🏽 🤷🏽‍♀️…

1 · Reply

Craigknowsbest Mar. 19 at 2:55 PM

2 · Reply

Weerasuk1994 Mar. 19 at 2:10 PM

$IVF very good 💩💩💩💩

0 · Reply

Traydsman Mar. 19 at 2:33 AM

$IVF

0 · Reply

Gamecock1 Mar. 18 at 2:59 PM

3 · Reply

Topdog007 Mar. 18 at 2:28 PM

$IVF should be at 0 in 1 month. Goes down 2 cents per day, only 36 days left and we are at 0 👍👍 keep up the good work management

0 · Reply

Topdog007 Mar. 18 at 1:43 PM

$IVF CEO

0 · Reply

Topdog007 Mar. 18 at 1:42 PM

$IVF CFO

0 · Reply

Topdog007 Mar. 18 at 1:42 PM

$IVF PURE HORSESHIT

1 · Reply

Topdog007 Mar. 18 at 1:14 PM

$IVF piece of trash company. Go to the pink sheets u junk trash

0 · Reply

Topdog007 Mar. 18 at 12:44 PM

$IVF make sure to go down again today INVO make it 300 straight days of decline. Don't go up even 1% fukin horseshit company

1 · Reply

FastRocketTraders Mar. 17 at 10:35 PM

$IVF Bullish

1 · Reply

Topdog007 Mar. 17 at 6:47 PM

$IVF the CEO has a bachelor's degree LOL clown

1 · Reply

Topdog007 Mar. 17 at 6:46 PM

$IVF

0 · Reply

Topdog007 Mar. 17 at 6:45 PM

$IVF CALL STEVE SHUM TELL HIM TO RESIGN

0 · Reply

Topdog007 Mar. 17 at 6:44 PM

$IVF Sales Director

0 · Reply

Topdog007 Mar. 17 at 6:44 PM

$IVF

0 · Reply

Topdog007 Mar. 17 at 6:43 PM

$IVF CFO of INVO

0 · Reply

Topdog007 Mar. 17 at 6:43 PM

$IVF biggest piece of shit i ever bought. It was for the Biotech side not the ivf side but dumb ass management carved out the Biotech piece and left us with the stupid preserved egg technology that they don't know how to market or sell Bunch of idiots Here's the CEO

0 · Reply

Topdog007 Mar. 17 at 6:37 PM

$IVF management doing a great job, only down 98.72% in the past year! Great job. Promote those muppets

1 · Reply

Topdog007 Mar. 17 at 12:56 PM

$IVF FBI needs to investigate this management team

1 · Reply

Market Cap	5.13M
Revenue (ttm)	6.53M
Net Income (ttm)	-9.10M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-139.36%
Debt to Equity Ratio	0.19

Volume	181,600
Avg Vol	8,687,350
Day's Range	N/A - N/A
Shares Out	6.96M
Stochastic %K	3%
Beta	2.66
Analysts	Strong Sell
Price Target	$4.00